These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2831853)

  • 1. Zwitterionic detergent solubilisation of HSV-1 surface antigens.
    Jennings R; Quasim T; Sharrard RM; Hockley D; Potter CW
    Arch Virol; 1988; 98(3-4):137-53. PubMed ID: 2831853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of HSV-1 antigens solubilised from infected cells by using non-ionic or zwitterionic detergents.
    Jennings R; Erturk M
    J Med Virol; 1990 Jun; 31(2):98-108. PubMed ID: 2167352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and immunogenicity of HSV-1 antigens obtained following zwitterionic detergent treatment.
    Mukhlis FA; Jennings R; Stephenson TJ; Quasim T; Potter CW
    Vaccine; 1986 Sep; 4(3):191-6. PubMed ID: 3020821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection and serum antibody responses in guinea-pigs and mice immunized with HSV-1 antigen preparations obtained using different detergents.
    Ertürk M; Welch MJ; Phillpotts RJ; Jennings R
    Vaccine; 1989 Oct; 7(5):431-6. PubMed ID: 2554607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent HSV-1 infection in mice immunized with a zwitterionic detergent-extracted HSV-1 antigen preparation.
    al-Ghamdi A; Jennings R; Bentley H; Potter CW
    Arch Virol; 1989; 108(1-2):19-31. PubMed ID: 2556982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a zwitterionic detergent for the preparation of an influenza virus vaccine: 2. Immunogenicity of Empigen-treated virus in animals.
    Mukhlis FA; Crawford CR; Jennings R; Potter CW
    Vaccine; 1984 Sep; 2(3):199-203. PubMed ID: 6531962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems.
    Mohamedi SA; Brewer JM; Alexander J; Heath AW; Jennings R
    Vaccine; 2000 Apr; 18(20):2083-94. PubMed ID: 10715522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virions.
    Crawford CR; Mukhlis FA; Jennings R; Oxford JS; Hockley DJ; Potter CW
    Vaccine; 1984 Sep; 2(3):193-8. PubMed ID: 6531961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses and protection in mice immunized with herpes simplex virus type 1 antigen immune-stimulating complex preparations.
    Ertürk M; Jennings R; Hockley D; Potter CW
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2149-55. PubMed ID: 2769234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective immunization of mice with specific HSV-1 glycoproteins.
    Chan WL
    Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J; Szczesiul MS; Marlin SD; Levine M
    Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossed immunoelectrophoretic studies of the solubility immunogenicity of herpes simplex virus antigens.
    Vestergaard BF; Bjerrum OJ; Norrild B; Grauballe PC
    J Virol; 1977 Oct; 24(1):82-90. PubMed ID: 198588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems.
    Hassan Y; Brewer JM; Alexander J; Jennings R
    Vaccine; 1996 Dec; 14(17-18):1581-9. PubMed ID: 9032885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of monoclonal antibodies to HSV-1 and HSV-2 for serological analysis of the viral glycoproteins.
    Pereira L
    Dev Biol Stand; 1982; 52():115-31. PubMed ID: 6299824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typing of herpes simplex virus types 1 and 2 by immunoblotting analysis using polyclonal antisera to herpes simplex virus glycoproteins.
    Okazaki K; Chiya S; Ideguchi S; Kimura S
    J Virol Methods; 1987 Nov; 18(2-3):169-78. PubMed ID: 2828400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.